“[O]ur results indicate MgT [magnesium-L-threonate] can significantly attenuate MPTP-induced motor deficits and DA [dopaminergic] neuron injury, which may be related to its ability of increasing the Mg [magnesium] concentration in the CSF [cerebrospinal fluid],”
PNT article: Oral Magnesium Compound Able to Reach Brain Seen to Slow Motor Decline, Neuronal Loss in Early Study [in mice].
parkinsonsnewstoday.com/201...
Research paper (open access): Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease (2019).
'Reverse Parkinson' by breathing-in Farnesol with a humidifier?
Could Butyrate Be Bad for PWP? (MIT Study)
From S of PD. Could all the benefit of B1 be the placebo affect? I think it's time for me to switch to benfotiamine instead.
